Eton Pharmaceuticals (ETON) Capital Expenditures Growth (1y) (2019 - 2025)
Eton Pharmaceuticals (ETON) Capital Expenditures Growth (1y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.15 Bn | 87.28 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.85 Bn | 32.11 Bn | 1.97 Bn | 32.28% |
| 3 | Zoetis | 32.52 Bn | 30.58 Bn | 1.62 Bn | -38.20% |
| 4 | Takeda Pharmaceutical | 27.53 Bn | 23.47 Bn | 4.39 Bn | -15.72% |
| 5 | United Therapeutics | 23.21 Bn | 21.06 Bn | 648.10 Mn | 32.98% |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - | - |
| 7 | Viatris | 20.30 Bn | 18.50 Bn | 1.16 Bn | -6.34% |
| 8 | Neurocrine Biosciences | 17.74 Bn | 16.42 Bn | 800.70 Mn | -86.92% |
| 9 | Elanco Animal Health | 12.59 Bn | 12.16 Bn | 785.00 Mn | -21.54% |
| 10 | Eton Pharmaceuticals | 1.15 Bn | 1.13 Bn | 13.10 Mn | 308.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 308.33% |
| Dec 31, 2022 | 200.00% |
| Dec 31, 2021 | -90.91% |
| Sep 30, 2021 | 0.00% |
| Dec 31, 2020 | 29.41% |
| Sep 30, 2020 | -93.75% |
| Mar 31, 2020 | -92.16% |
| Dec 31, 2019 | -37.04% |
| Sep 30, 2019 | -36.00% |
| Jun 30, 2019 | 2,287.80% |
| Mar 31, 2019 | -43.96% |